All-Party Parliamentary Group
on Vascular and Venous Disease

About the Group’s 2016 inquiry into access to medical technologies for the diagnosis and treatment of Peripheral Arterial Disease.

June – December 2016

Over 11,500 lower limb amputations are carried out every year, the vast majority of which are as a direct result of Peripheral Arterial Disease (PAD), diabetes or commonly a combination of the two.

  1. Past inquiries from the Group and information received from Diabetes UK have revealed that 5,000 serious amputations every year could be prevented.
  2. Up to 80% of people die within five years of having an amputation.
  3. Given these poor mortality outcomes for patients following a major amputation, many clinicians, patient groups and members of the Group believe that major lower limb amputation should be seen as a failure of treatment rather than a treatment option.

A previous inquiry identified that use of new technologies can improve blood flow in the foot and lower limb and potentially avoid major amputation. Moreover, the National Institute for Health and Care Excellence (NICE) began to review guidance on the treatment of PAD and the use of technology in September 2016.

For these reasons the Group decided to conduct a brief inquiry into patient access to technology to avoid lower limb amputation. The findings from the inquiry were consolidated into a final report, which can be downloaded here.